EMA waives fees for orphan drug consultations
European Medicines agency (EMA) updates their executive decision for orphan drug development of waiving fees for academic organizations.
Tag: health authority consultation
European Medicines agency (EMA) updates their executive decision for orphan drug development of waiving fees for academic organizations.
Copyright ©2023 Global Regulatory Partners